Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cystic fibrosis prognosis in Europa : chronicle of an announced dilemma].

Revue medicale de Liege - 1 Mar 2021

Lebecque P, Thimmesch M

Abstract excerpt

In cystic fibrosis, lung disease is early and insidious. It almost always conditions the prognosis. A pragmatic way of looking at prognostic factors is to distinguish those on which care management has little (environmental factors) or no grip (genetic factors) and those related to the quality of care, the latter being crucial. Recently, a triple-combination CFTR («Cystic Fibrosis Transmembrane conductance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Aminopyridines
Share to Benzodioxoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Cystic Fibrosis Transmembrane Conductance Regulator

Share to Europe

Share to Prognosis

Share to Quinolones

Source

Identifiers

PMID: 33682390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cystic fibrosis prognosis in Europa : chronicle of an announced dilemma].PMID 33682390Read ↗

[Therapeutics in cystic fibrosis: Clinical revolution and new challenges].Semantic proximity Read ↗

[Cystic fibrosis in 2008].Semantic proximity Read ↗

[Cystic fibrosis - ETI and type 2 N-of-1 trials : the next step].Semantic proximity Read ↗

The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.Semantic proximity Read ↗

[Therapeutic update in cystic fibrosis].Semantic proximity Read ↗

[Evidence-based treatment of cystic fibrosis].Semantic proximity Read ↗

[News drugs and evolution towards personalized treatment for cystic fibrosis].Semantic proximity Read ↗

Unmet needs in cystic fibrosis.Semantic proximity Read ↗

Optimising the care and quality of life of people with cystic fibrosis: the influence of cystic fibrosis transmembrane conductance regulator modulators.Semantic proximity Read ↗

[New advances in the management and treatment of cystic fibrosis].Semantic proximity Read ↗

Predictive factors of survival in people with cystic fibrosis from a Spanish rare disease registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.